# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-029334
Filing Date
2023-08-14
Accepted
2023-08-14 16:02:06
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vyne-20230630.htm iXBRL | 10-Q | 827862
2 | EX-10.1 | orallicense-forsecfiling.htm | EX-10.1 | 434853
3 | EX-31.1 | vyne-20230630xexx311.htm | EX-31.1 | 9607
4 | EX-31.2 | vyne-20230630xexx312.htm | EX-31.2 | 9601
5 | EX-32.1 | vyne-20230630xexx321.htm | EX-32.1 | 5245
6 | EX-32.2 | vyne-20230630xexx322.htm | EX-32.2 | 5240
12 |  | image_1.jpg | GRAPHIC | 43608
| Complete submission text file | 0001628280-23-029334.txt |  | 4760704

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20230630.xsd | EX-101.SCH | 30281
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20230630_cal.xml | EX-101.CAL | 48854
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20230630_def.xml | EX-101.DEF | 163558
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20230630_lab.xml | EX-101.LAB | 396226
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20230630_pre.xml | EX-101.PRE | 265405
45 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20230630_htm.xml | XML | 421635

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 231169602
SIC: 2834 Pharmaceutical Preparations